NEW YORK (GenomeWeb) – PointCross Life Sciences today announced a strategic partnership to integrate its RDIS data platform with InterpretOmics iOmics genomic analysis software tools.
The partners will work together to analyze genomic biomarkers collected in clinical trials and other studies.
"The integration of our RDIS platform with iOmics allows us to address critical industry needs with a visionary integration capable of exploiting diverse data types to identify important safety and efficacy signals," PointCross VP Shree Nath said in a statement.
Financial and other details of the agreement were not disclosed.